Relationship of ACE1 and ACE2 genetic polymorphisms on SARS-CoV-2 infection and severity of symptoms in different regions of Iraq
Article Sidebar
Main Article Content
Abstract
This study was conducted in the laboratories of the Biology Department - College of Science - Tikrit University, the laboratories of the Food Science Department - College of Agriculture - University of Anbar, and the Public Health Laboratories - Anbar for the period from December 2021 AD until February 2022 AD, study involved taking samples from hospitalized COVID-19 patients of both sexes, after a confirmed positive PCR test result. As well as those lying in quarantine in three Iraqi governorates (the isolation unit in Karkh, Yarmouk and Kadhimiya hospitals, the Al-Shifa quarry hospital in Anbar, the public health laboratory in Anbar, and the quarantine hospital for thousands in Erbil), in addition to outpatient clinics. They were distributed by 30 patients and 20 healthy subjects from each governorate, with ages ranging from 18-80 years, randomly to men and women in order to determine the role of genetic polymorphisms in the ACE inhibitor gene in the study samples. The results of the genetic polymorphisms of ACE-1rs4646994, ACE-2rs2106809, and ACE-2rs4240157 showed that there were non-significant differences between the frequency of alleles and genotypes in the patient's group compared with the healthy group. The DD mutant genotype of ACE-1rs4646994 appeared in the patient's group in Baghdad and Anbar with a high percentage, while patients in Erbil showed the highest percentage of the heterozygous genotype ID compared to healthy subjects, with an OR= 0.922, OR= 2.750, and OR= 1.118, respectively, for the mutant allele D. Therefore, it is not considered a risk factor for the disease in Baghdad, in contrast to Anbar and Erbil. The polymorphism of ACE-2rs2106809, the homozygous genotype CC was dominant in patients in the aforementioned provinces and may not be considered a risk factor for the disease. The results of ACE-2rs4240157 gene polymorphism, the heterozygous CT genotype showed a high percentage in patients in Baghdad and, while in Anbar patients, the normal genotype TT appeared to be the highest percentage compared to healthy subjects. The C mutant allele in Baghdad, Anbar, and Erbil patients reached OR= 1.306, OR= 4.333, and OR= 9.00, respectively, so this allele is considered a risk factor for the disease. We can conclude from this study the role of each of the polymorphisms rs4646994 ACE-1 and rs4240157 ACE-2 in infection with COVID-19 and the severity of its symptoms according to the geographical region and race, in contrast to rs2106809 ACE-2, as it is possible to conduct clinical studies to demonstrate the role of genetic polymorphisms with Relationship to diseases depending on the region and race.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Gudi, S. K., and Tiwari, K. K. (2020). Preparedness and lessons learned from the novel coronavirus disease. The International Journal of Occupational and Environmental Medicine, 11(2), 108. [2] Al-Mudhaffer, R. H., Ahjel, S. W., Hassan, S. M., Mahmood, A. A., & Hadi, N. R. (2020). Age Distribution of clinical symptoms, isolation, co-morbidities and Case Fatality Rate of COVID-19 cases in Najaf City, Iraq. Medical Archives, 74(5), 363. [3] Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J., Pfeffer, M. A., & Solomon, S. D. (2020). Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. New England Journal of Medicine, 382(17), 1653-1659. [4] Pagliaro, P., & Penna, C. (2020). ACE/ACE2 ratio: a key also in 2019 coronavirus disease (Covid-19)?. Frontiers in medicine, 7, 335. [5] Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science, 367(6485), 1444-1448.
[6] Verma, S., Abbas, M., Verma, S., Khan, F. H., Raza, S. T., Siddiqi, Z., ... & Mahdi, F. (2021). Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients. Infection, Genetics and Evolution, 91, 104801. [7] Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2017). The ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1–7). Physiological reviews.
[8] Yuda, P., and Saputra, A. W. (2020). Eggshell membrane for DNA sexing of the endangered Maleo (Macrocephalon maleo). F1000Research, 9(955),1- 12. [9] Keikha, M., & Karbalaei, M. (2022). Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis. Microbial Pathogenesis, 105781. [10] Wang, J., Zou, H., & Corpe, C. (2022). An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China. Journal of Infection, 84(1), e21-e22. [11] Hamet, P., Pausova, Z., Attaoua, R., Hishmih, C., Haloui, M., Shin, J., ... & Tremblay, J. (2021). SARS–CoV-2 receptor ACE2 gene is associated with hypertension and severity of COVID 19: interaction with sex, obesity, and smoking. American journal of hypertension, 34(4), 367-376. [12] Keikha, M., & Karbalaei, M. (2022). Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis. Microbial [13] Mir, M. M., Mir, R., Alghamdi, M. A. A., Alsayed, B. A., Wani, J. I., Alharthi, M. H., & Al-Shahrani, A. M. (2021). Strong association of angiotensin converting enzyme-2 gene insertion/deletion polymorphism with susceptibility to SARS-CoV-2, hypertension, coronary artery disease and COVID-19 disease mortality. Journal of personalized medicine, 11(11), 1098. [14] Zheng, H., & Cao, J. J. (2020). Angiotensin-converting enzyme gene polymorphism and severe lung injury in patients with coronavirus disease 2019. The American journal of pathology, 190(10), 2013-2017. [15] Saengsiwaritt, W., Jittikoon, J., Chaikledkaew, U., & Udomsinprasert, W. (2022). Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID‐19 severity: A systematic review with meta‐analysis. Reviews in medical virology, 32(4), e2323. [16] Karakaş Çelik, S., Çakmak Genç, G., Pişkin, N., Açikgöz, B., Altinsoy, B., Kurucu İşsiz, B., & Dursun, A. (2021). Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID‐19: A case study. Journal of Medical Virology, 93(10), 5947-5952. [17] Pouladi, N., & Abdolahi, S. (2021). Investigating the ACE2 polymorphisms in COVID‐19 susceptibility: An in silico analysis. Molecular Genetics & Genomic Medicine, 9(6), e1672. [18] Sabater Molina, M., Nicolás Rocamora, E., Bendicho, A. I., Vázquez, E. G., Zorio, E., Rodriguez, F. D., ... & Gimeno Blanes, J. R. (2022). Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease. PLoS One, 17(2), e0263140. [19] Mohammadi-Berenjestanaki, H., Mohammadali, E., Khasayesi, M., Rafiei, A., Kashi, Z., Mirzaei-Ilali, N., & Hosseini-Khah, Z. (2023). Association between angiotensin-converting enzyme-2 gene polymorphism (rs2106809) with severity and outcome of COVID-19 infection. Molecular Biology Reports, 1-11.
[20] Suleiman, A., Rafaa, T., Alrawi, A., & Dawood, M. (2021). The impact of ACE2 genetic polymorphisms (rs2106809 and rs2074192) on gender susceptibility to COVID-19 infection and recovery: A systematic review. Baghdad Journal of Biochemistry and Applied Biological Sciences, 2(03), 167-180. [21] Cafiero, C., Rosapepe, F., Palmirotta, R., Re, A., Ottaiano, M. P., Benincasa, G., ... & Pisconti, S. (2021). Angiotensin system polymorphisms’ in SARS-CoV-2 positive patients: assessment between symptomatic and asymptomatic patients: a pilot study. Pharmacogenomics and personalized medicine, 621-629. [22] Sieńko, J., Kotowski, M., Bogacz, A., Lechowicz, K., Drożdżal, S., Rosik, J., ... & Kotfis, K. (2020). COVID-19: the influence of ACE genotype and ACE-I and ARBs on the course of SARS-CoV-2 infection in elderly patients. Clinical Interventions in Aging, 1231-1240. [23] Wooster, L., Nicholson, C. J., Sigurslid, H. H., Lino Cardenas, C. L., & Malhotra, R. (2020). Polymorphisms in the ACE2 locus associate with severity of COVID-19 infection. MedRxiv, 2020-06. [24] Ali, Z. H., Al-Marzoqi, A. H., & Rahmaan, N. (2023). Cancer patients with Angiotensin-converting enzyme (ACE) gene polymorphism and COVID-19 phenotypic expression predisposed to SARS-CoV-2 infection. Journal of Applied and Natural Science, 15(2), 754-759. [25] Liu, L. P., Zhang, X. L., & Li, J. (2021). New perspectives on angiotensin-converting enzyme 2 and its related diseases. World Journal of Diabetes, 12(6), 839.